CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer

The 1100delC mutation in the CHEK2 gene has a carrier frequency of up to 1.5% in individuals from North-West Europe. Women heterozygous for 1100delC have an increased breast cancer risk (odds ratio 2.7). To explore the prevalence and clinical consequences of 1100delC homozygosity in the Netherlands,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Huijts, Petra EA, Hollestelle, Antoinette, Balliu, Brunilda, Houwing-Duistermaat, Jeanine J, Meijers, Caro M, Blom, Jannet C, Ozturk, Bahar, Krol-Warmerdam, Elly MM, Wijnen, Juul, Berns, Els MJJ, Martens, John WM, Seynaeve, Caroline, Kiemeney, Lambertus A, van der Heijden, Henricus F, Tollenaar, Rob AEM, Devilee, Peter, van Asperen, Christi J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865411/
https://ncbi.nlm.nih.gov/pubmed/23652375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2013.85
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados